MSC

Elika Verma1, Mehak Gupta1, Riley Sierhuis1

  • 1Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre Regenerative Medicine Program, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Biomedical Engineering Program, University of Manitoba, Winnipeg, Manitoba R2H2A6, Canada.

概括

对心血管疾病中介质干细胞 (MSC) 治疗的研究越来越多地关注性别特异性差异. 这一转变凸显了基于男性和女性生物差异的个性化治疗的必要性,以改善结果.